Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M252,847Revenue $M71,882Net Margin (%)22.4Altman Z-Score5.1
Enterprise Value $M238,200EPS $5.7Operating Margin %27.3Piotroski F-Score6
P/E(ttm)16.0Beneish M-Score-2.6Pre-tax Margin (%)29.0Higher ROA y-yN
Price/Book3.510-y EBITDA Growth Rate %4.3Quick Ratio2.2Cash flow > EarningsY
Price/Sales3.65-y EBITDA Growth Rate %3.5Current Ratio2.5Lower Leverage y-yN
Price/Free Cash Flow19.1y-y EBITDA Growth Rate %7.9ROA % (ttm)12.2Higher Current Ratio y-yY
Dividend Yield %3.2PEG4.8ROE % (ttm)22.2Less Shares Outstanding y-yY
Payout Ratio %50.0Shares Outstanding M2,773ROIC % (ttm)26.6Gross Margin Increase y-yY

Gurus Latest Trades with JNJ

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
JNJJoel Greenblatt 2015-06-30 Sold Out -0.64%$97.46 - $103.96
($100.15)
$ 91.31-9%Sold Out0
JNJYacktman Focused Fund 2015-06-30 Reduce-0.6%$97.46 - $103.96
($100.15)
$ 91.31-9%Reduce 16.67%2,500,000
JNJDonald Yacktman 2015-06-30 Reduce-0.46%$97.46 - $103.96
($100.15)
$ 91.31-9%Reduce 11.75%7,441,948
JNJYacktman Fund 2015-06-30 Reduce-0.37%$97.46 - $103.96
($100.15)
$ 91.31-9%Reduce 10.26%3,500,000
JNJTweedy Browne 2015-06-30 Reduce-0.37%$97.46 - $103.96
($100.15)
$ 91.31-9%Reduce 3.38%3,918,801
JNJJohn Rogers 2015-06-30 Add0.14%$97.46 - $103.96
($100.15)
$ 91.31-9%Add 19.02%782,026
JNJDavid Dreman 2015-06-30 Buy 0.05%$97.46 - $103.96
($100.15)
$ 91.31-9%New holding6,648
JNJKen Fisher 2015-06-30 Add0.04%$97.46 - $103.96
($100.15)
$ 91.31-9%Add 1.77%10,641,756
JNJJames Barrow 2015-06-30 Reduce-0.01%$97.46 - $103.96
($100.15)
$ 91.31-9%Reduce 0.28%15,632,757
JNJMario Gabelli 2015-06-30 Reduce-0.01%$97.46 - $103.96
($100.15)
$ 91.31-9%Reduce 5.40%315,150
JNJRichard Pzena 2015-06-30 Add$97.46 - $103.96
($100.15)
$ 91.31-9%Add 0.01%1,174,169
JNJFirst Eagle Investment 2015-06-30 Reduce$97.46 - $103.96
($100.15)
$ 91.31-9%Reduce 1.09%1,610,098
JNJDodge & Cox 2015-06-30 Reduce$97.46 - $103.96
($100.15)
$ 91.31-9%Reduce 4.38%38,235
JNJRuane Cunniff 2015-06-30 Add$97.46 - $103.96
($100.15)
$ 91.31-9%Add 1.87%77,357
JNJTweedy Browne 2015-03-31 Reduce-0.23%$98.32 - $106.39
($101.69)
$ 91.31-10%Reduce 2.09%4,055,962
JNJMichael Price 2015-03-31 Reduce-0.13%$98.32 - $106.39
($101.69)
$ 91.31-10%Reduce 28.57%25,000
JNJYacktman Focused Fund 2015-03-31 Reduce-0.11%$98.32 - $106.39
($101.69)
$ 91.31-10%Reduce 3.23%3,000,000
JNJDonald Yacktman 2015-03-31 Reduce-0.08%$98.32 - $106.39
($101.69)
$ 91.31-10%Reduce 2.08%8,432,672
JNJJoel Greenblatt 2015-03-31 Add0.03%$98.32 - $106.39
($101.69)
$ 91.31-10%Add 5.40%833,196
JNJJohn Rogers 2015-03-31 Add0.03%$98.32 - $106.39
($101.69)
$ 91.31-10%Add 3.95%657,074
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

JNJ is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


JNJ: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
PRINCE CHARLESDirector 2015-08-06Buy2,500$99.25-8.46view
PRINCE CHARLESDirector 2015-06-02Buy2,500$99.22-8.44view
Stoffels PaulusChief Scientific Officer 2015-04-28Sell187,250$100.73-9.81view
Fasolo PeterVP, Global Human Resources 2015-03-05Sell115,307$102.4-11.28view
COSGROVE STEPHEN JCorporate Controller 2014-11-05Sell2,490$108.55-16.31view
Ullmann Michael HVP, General Counsel 2014-10-31Sell17,350$107.43-15.43view
CULLEN JAMESDirector 2014-09-10Sell2,446$104.12-12.74view
Caruso Dominic JVP, Finance; CFO 2014-08-21Sell30,000$104.3-12.9view
COSGROVE STEPHEN JCorporate Controller 2014-05-05Sell22,000$100.05-9.2view
Fasolo PeterVP, Global Human Resources 2014-03-14Sell6,824$93.15-2.47view

Press Releases about JNJ :

Quarterly/Annual Reports about JNJ:

    News about JNJ:

    Articles On GuruFocus.com
    The Two Keys to the Magic Formula for Long-Term Investment Success Sep 03 2015 
    Moseley Holdings Aug 30 2015 
    Five High-Quality Dividend Growth Stocks That Look Very Appealing After Recent Volatility Aug 27 2015 
    AptarGroup: The Leader in Dispensing Innovation Aug 21 2015 
    Valeant Pharmaceuticals' New Female Drug Aug 20 2015 
    JNJ – Should It Be In Your Portfolio? Aug 19 2015 
    AbbVie: The Riskiest Dividend Aristocrat Aug 18 2015 
    focused portfolio Aug 18 2015 
    Long-Term Study: Relative Historical Yield & High Quality Businesses Aug 15 2015 
    Tweedy Browne Reduces 33 Stakes in Portfolio Aug 10 2015 

    More From Other Websites
    Merck: Analyzing the Company’s Growth Rate Sep 04 2015
    Big Pharma: The Moment of Dread Is Here Sep 03 2015
    The 4 Stocks That Weighed on the DJIA Thursday Sep 03 2015
    The Two Keys to the Magic Formula for Long-Term Investment Success Sep 03 2015
    Johnson & Johnson to Participate in the 2015 Morgan Stanley Healthcare Conference Sep 03 2015
    Johnson & Johnson to Participate in the 2015 Morgan Stanley Healthcare Conference Sep 03 2015
    Research and Markets: Investigation Report on China's Rivaroxaban Market, 2010-2019 Sep 03 2015
    Stocks for the Coming Ice Age Sep 02 2015
    S&P 500 Index Retreats From Highs Sep 02 2015
    4 Companies Affected by the Appreciating Dollar Sep 02 2015
    9:11 am Johnson & Johnson's Janssen unit announces the approval of a FDA sBLA for SIMPONI ARIA for... Sep 02 2015
    3 ways Tampa Bay can capitalize on the Johnson & Johnson deal Sep 01 2015
    5 High-Yielding Strong Dividend Growth Stocks for the Long Haul Aug 31 2015
    The Zacks Analyst Blog Highlights: 3M Company, General Electric, Intel and Johnson & Johnson Aug 31 2015
    Janssen Pharmaceuticals Accused of Hiding Risperdal's Breast Effects In Boys Aug 29 2015
    The 4 Stocks That Held Down the DJIA on Friday Aug 28 2015
    Stocks near session lows Aug 28 2015
    Johnson & Johnson to Participate in the 2015 Wells Fargo 10th Annual Healthcare Conference Aug 28 2015
    Dow 30 Stock Roundup: 3M Lowers 2015 Earnings Outlook, JNJ Subsidiary Sells Splenda Aug 28 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    Gurufocus
    ReplyGurufocus - 1 year ago
    test
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK